Investors Radio in $32M for Vanu, JumpTap’s Bank Balance Hops up by $26M, Quanterix Pinpoints $15M, & More Deals News

While many of us were cutting out early for the holiday weekend, and to enjoy the last week of summer, New England tech and life sciences firms were cutting a surprising number of deals.

—Tufts spinoff Quanterix closed the second half of a $15 million financing round from Arch Venture Partners, Bain Capital Ventures, and Flagship Ventures. Luke talked with the Cambridge, MA-based firm’s CEO about its technology for pinpointing minute quantities of proteins in a patient’s blood that might serve as early warning signals for cancer, Alzehimer’s disease, or other ailments.

—Lexington, MA-based Mall Networks, which creates online malls that give loyalty cardholders bonus points for shopping, raised $7 million in a Series B investment led by Dace Ventures and joined by previous investors Flybridge Capital Partners, Venture Capital Fund of New England, and LBO Enterprises.

—Living Proof of Cambridge, MA, raised $7 million Series A-3 financing from Polaris Venture Partners and other investors. Though it tries to keep a low profile, the startup is using the expertise of some very high-profile scientists, investors, and executives to address the multi-billion-dollar market for beauty products.

—Cambridge, MA-based JumpTap, which provides mobile Web search and advertising technology for a variety of phones from AT&T, Alltel, Boost Mobile, U.S. Cellular, and a host of other carriers, closed a $26 million Series D financing round. The deal was led by AllianceBernstein and joined by existing investors General Catalyst Partners, Summerhill Venture Partners, Redpoint Ventures, Valhalla Partners, and WPP.

—Specialty pharmaceutical maker Indevus Pharmaceuticals (NASDAQ:[[ticker:INDEV]]) raised $105 million in a private placement of notes secured by royalties for Sanctura, the Lexington, MA-based firm’s drug for overactive bladder.

—Software-defined-radio startup Vanu of Cambridge, MA, reportedly took in $32 million a Series B venture round from Charles River Ventures, Norwest Venture Partners, and Tata Capital. The firm’s technology allows wireless operators to broadcast to use multiple standards such as GSM and CDMA.

—Dover, NH-based Salient Surgical Technologies, a maker of blood-vessel-sealing devices, pulled its planned $86.25 million initial public offering.

—Boston-based uLocate inked a deal to provide local information and mapping services for Sprint’s new nationwide WiMax network, XOHM, now under construction.

Author: Rebecca Zacks

Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.